|

SGLT-2 inhibitor Clinical Trials

2 actively recruiting trials

Also known as: Empagliflozin, Sodium-glucose cotransporter-2 (SGLT2) inhibitors

Pipeline

Phase 1: 1

Top Sponsors

  • Sheffield Teaching Hospitals NHS Foundation Trust1
  • McGill University1

Indications

  • Heart Failure With Preserved Ejection Fraction (HFPEF)1
  • T1D1
  • Type1diabetes1
  • Heart Disease1
  • Diabetes1

Other2 trials

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Phase 1
The Use of Advanced Imaging in HFpEF

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.